MRI System Correction: Siemens Healthineers Issues Correction for 3 Tesla MRI Systems

This technical specifications document represents the Food and Drug Administration’s (FDA’s) current thinking on this topic.

The FDA maintains a list of approved new drug application (NDA) drug products that are no longer protected by patents or exclusivities, and for which the FDA has not approved an ANDA referencing that NDA drug product.

Fukuzyu Pharmaceutical Co., Ltd. – 1/19/2024. Country: Japan. Record Type: 483

CGMP/Finished Pharmaceuticals/Adulterated

Conducting Remote Regulatory Assessments Questions and Answers Guidance for Industry

The DSB is composed of representatives from two FDA Centers and eight other federal government agencies, the Agency for Healthcare Research and Quality, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services, Department of Defense.